EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.4.1.244 | Colonic Neoplasms |
17395692 |
Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
3
1
0 |
| 2.4.1.244 | Colonic Neoplasms |
17579116 |
Beta1,4-N-acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells. |
causal interaction
ongoing research
unassigned |
4
4
0 |
| 2.4.1.244 | Colonic Neoplasms |
25003232 |
?1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
3
2 |
| 2.4.1.244 | Colorectal Neoplasms |
25003232 |
?1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
3
2 |
| 2.4.1.244 | Neoplasm Metastasis |
17579116 |
Beta1,4-N-acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells. |
causal interaction
ongoing research
unassigned |
4
4
0 |
| 2.4.1.244 | Neoplasms |
17579116 |
Beta1,4-N-acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells. |
causal interaction
ongoing research
unassigned |
4
4
0 |
| 2.4.1.244 | Neoplasms |
21741930 |
B4GALNT3 Expression Predicts a Favorable Prognosis and Suppresses Cell Migration and Invasion via ?(1) Integrin Signaling in Neuroblastoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
4
4
0 |
| 2.4.1.244 | Neoplasms |
25003232 |
?1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
3
2 |
| 2.4.1.244 | Neoplasms |
28853212 |
Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma. |
causal interaction
diagnostic usage
unassigned |
3
3
0 |
| 2.4.1.244 | Neuroblastoma |
21741930 |
B4GALNT3 Expression Predicts a Favorable Prognosis and Suppresses Cell Migration and Invasion via ?(1) Integrin Signaling in Neuroblastoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
4
4
0 |
